Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124488653 | 12448865 | 3 | F | 20160309 | 20160713 | 20160608 | 20160725 | EXP | IT-MINISAL02-361308 | IT-TEVA-666252ACC | TEVA | 45.25 | YR | F | Y | 0.00000 | 20160725 | MD | IT | IT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124488653 | 12448865 | 1 | PS | GABAPENTIN. | GABAPENTIN | 1 | Oral | Y | 76017 | ||||||||||
| 124488653 | 12448865 | 2 | SS | LITHIUM. | LITHIUM | 1 | Oral | Y | 76170 | ||||||||||
| 124488653 | 12448865 | 3 | SS | LITHIUM. | LITHIUM | 1 | Y | 76170 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124488653 | 12448865 | 1 | Self-injurious ideation |
| 124488653 | 12448865 | 2 | Depression |
| 124488653 | 12448865 | 3 | Self-injurious ideation |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124488653 | 12448865 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124488653 | 12448865 | Drug abuse | |
| 124488653 | 12448865 | Intentional self-injury | |
| 124488653 | 12448865 | Toxicity to various agents |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |